Vanda Pharmaceuticals Inc (VNDA.OQ)

VNDA.OQ on NASDAQ Stock Exchange Global Market

11.27USD
29 Jan 2015
Change (% chg)

$-0.20 (-1.74%)
Prev Close
$11.47
Open
$11.45
Day's High
$11.45
Day's Low
$10.71
Volume
261,325
Avg. Vol
216,105
52-wk High
$19.25
52-wk Low
$8.34

VNDA.OQ

Chart for VNDA.OQ

About

Vanda Pharmaceuticals Inc. is a biopharmaceutical company engaged in the development and commercialization of products for the treatment of central nervous system disorders. The Company’s product portfolio includes: HETLIOZ (tasimelteon), a product for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24); Fanapt (iloperidon... (more)

Overall

Beta: 1.94
Market Cap(Mil.): $454.80
Shares Outstanding(Mil.): 39.65
Dividend: --
Yield (%): --

Financials

  VNDA.OQ Industry Sector
P/E (TTM): -- 206.52 40.74
EPS (TTM): -1.69 -- --
ROI: -69.91 -0.84 18.19
ROE: -223.86 -2.65 19.08
Search Stocks

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks